The association of sex steroid hormone concentrations with non‐alcoholic fatty liver disease and liver enzymes in US men. (19th January 2021)

• Record Type: Journal Article
• Authors: Phan, Hong; Richard, Aline; Lazo, Mariana; Nelson, William G.; Denmeade, Samuel R.; Groopman, John; Kanarek, Norma; Platz, Elizabeth A.; Rohrmann, Sabine
• Is Part Of: Liver international. Volume 41:Number 2(2021)
• Page Start: 300
• Page End: 310
• Publication Date: 2021-01-19
• Subjects: estradiol -- hepatic steatosis -- non‐alcoholic fatty liver disease -- sex hormone‐binding globulin -- testosterone; Liver -- Periodicals; Liver -- Diseases -- Periodicals; 616.362
• DOI: 10.1111/liv.14652
• Languages: English
• ISSNs: 1478-3223

Abstract

Abstract: Background & Aims: This study aimed to analyse the association of sex hormone levels with liver enzyme levels and non‐alcoholic fatty liver disease (NAFLD) in a nationally representative sample of men. Methods: A total of 919 men from the US National Health and Nutrition Examination Study (NHANES) III were included in this cross‐sectional analysis of data from 1988 to 1991. We used existing data on serum total and free testosterone, total and free estradiol, androstanediol glucuronide (AAG) and sex steroid‐binding globulin (SHBG), and estimated their associations with aspartate aminotransferase (AST), and alanine aminotransferase (ALT) and NAFLD, as determined using ultrasound, after adjusting for possible confounders including age, race, smoking, alcohol, physical activity, waist circumference and steroid hormones. Results: Lower total testosterone (TT) and higher free estradiol were associated with higher odds of NAFLD after adjusting for confounders including the other sex hormones. Lower TT was associated with higher odds of elevated AST, but not ALT. Free testosterone, total estradiol, SHBG and AAG were not associated with NAFLD or liver enzymes. Conclusions: This study supports an inverse association between TT concentration and NAFLD in men independent of other sex hormones (SHBG, AAG and estradiol) and known risk factors, such as obesity, age and lifestyle. Exploration of whether TT might be a non‐invasive marker for NAFLD diagnosis is warranted.